Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy
2019 · Annals of Oncology · 504 citations
https://doi.org/10.1093/annonc/mdz117
S
Stefano Sestini
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
48
Papers
1.6K
Citations
16
h-index
18
i10-index
Stefano Sestini is an academic researcher from Fondazione IRCCS Istituto Nazionale dei Tumori. The author has contributed to research in topics: Lung Cancer Diagnosis and Treatment & Radiomics and Machine Learning in Medical Imaging & Cancer-related molecular mechanisms research. The author has an h-index of 16, co-authored 41 publications.
ORCID: 0000-0003-2274-9293Papers by this author
worksLow-dose computed tomography for lung cancer screening: comparison of performance between annual and biennial screen
2016 · European Radiology · 114 citations
https://doi.org/10.1007/s00330-016-4228-3
Baseline computed tomography screening and blood microRNA predict lung cancer risk and define adequate intervals in the BioMILD trial
2022 · Annals of Oncology · 97 citations
https://doi.org/10.1016/j.annonc.2022.01.008
Mutational Profile from Targeted NGS Predicts Survival in LDCT Screening–Detected Lung Cancers
2017 · Journal of Thoracic Oncology · 16 citations
https://doi.org/10.1016/j.jtho.2017.03.001
eComment. A bicycle inner tube in a glass of water! Video-assisted thoracoscopic surgery for spontaneous pneumothorax and the submersion test
2015 · Interactive Cardiovascular and Thoracic Surgery · 4 citations
https://doi.org/10.1093/icvts/ivv052
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat